StockCalc Blog

PennyMac Financial Servs (PFSI:NYS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report PennyMac Financial Servs(PFSI:NYS) Financial Services:Mortgage Finance This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$57.04 (USD) 05/07/2021 Weighted Valuation$58.14 (USD) Overall RatingFairly valued to slightly Undervalued by 1.9% …

PennyMac Financial Servs (PFSI:NYS) Fundamental Valuation Report Read more »

Plaza Retail REIT (PLZ.UN:TSE) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Plaza Retail REIT(PLZ.UN:TSE) Real Estate:REIT – Retail This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$3.99 (CAD) 05/07/2021 Weighted Valuation$4.01 (CAD) Overall RatingFairly valued to slightly Undervalued by …

Plaza Retail REIT (PLZ.UN:TSE) Fundamental Valuation Report Read more »

Pembina Pipeline (PPL:TSE) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Pembina Pipeline(PPL:TSE) Energy:Oil & Gas Midstream This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$38.06 (CAD) 05/07/2021 Weighted Valuation$37.75 (CAD) Overall RatingFairly valued to slightly Overvalued by 0.8% …

Pembina Pipeline (PPL:TSE) Fundamental Valuation Report Read more »

Perficient (PRFT:NAS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Perficient(PRFT:NAS) Technology:Information Technology Services This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$68.62 (USD) 05/07/2021 Weighted Valuation$63.92 (USD) Overall RatingOvervalued by 6.9% Valuation Models Comparables: $60.33 (USD) Comparables: $54.93 …

Perficient (PRFT:NAS) Fundamental Valuation Report Read more »

Petrus Resources (PRQ:TSE) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Petrus Resources(PRQ:TSE) Energy:Oil & Gas E&P This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$0.81 (CAD) 05/07/2021 Weighted Valuation$0.68 (CAD) Overall RatingOvervalued by 16.4% Valuation Models Comparables: $0.68 …

Petrus Resources (PRQ:TSE) Fundamental Valuation Report Read more »

Steelcase (SCS:NYS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Steelcase(SCS:NYS) Industrials:Business Equipment & Supplies This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$13.73 (USD) 05/12/2021 Weighted Valuation$14.60 (USD) Overall RatingUndervalued by 6.3% Valuation Models Comparables: $26.31 (USD) …

Steelcase (SCS:NYS) Fundamental Valuation Report Read more »

E W Scripps (SSP:NAS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report E W Scripps(SSP:NAS) Communication Services:Broadcasting This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$19.78 (USD) 05/12/2021 Weighted Valuation$21.28 (USD) Overall RatingUndervalued by 7.6% Valuation Models Adjusted Book …

E W Scripps (SSP:NAS) Fundamental Valuation Report Read more »

Provention Bio (PRVB:NAS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Provention Bio(PRVB:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$6.80 (USD) 05/12/2021 Weighted Valuation$12.62 (USD) Overall RatingUndervalued by 85.5% Valuation Models Comparables: $12.94 (USD) Adjusted Book …

Provention Bio (PRVB:NAS) Fundamental Valuation Report Read more »

Personalis (PSNL:NAS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report Personalis(PSNL:NAS) Healthcare:Diagnostics & Research This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$18.57 (USD) 05/12/2021 Weighted Valuation$29.48 (USD) Overall RatingUndervalued by 58.7% Valuation Models Comparables: $30.64 (USD) Multiples: $27.74 …

Personalis (PSNL:NAS) Fundamental Valuation Report Read more »

PTC Therapeutics (PTCT:NAS) Fundamental Valuation Report

By admin Posted on May 14, 2021 Posted in Fundamental Valuation Report

Fundamental Valuation Report PTC Therapeutics(PTCT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$38.29 (USD) 05/12/2021 Weighted Valuation$38.22 (USD) Overall RatingFairly valued to slightly Overvalued by 0.2% Valuation Models Multiples: $33.22 …

PTC Therapeutics (PTCT:NAS) Fundamental Valuation Report Read more »

Notice to User:

Risk Disclosure:
Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results.

Hypothetical Performance Disclosure:
Hypothetical performance results have many inherent limitations, some of which are described below. no representation is being made that any account will or is likely to achieve profits or losses similar to thoseshown; in fact, there are frequently sharp differences between hypothetical performance results and the actual results subsequently achieved by any particular trading program. One of the limitations of hypothetical performance results is that they are generally prepared with the benefit of hindsight. In addition, hypothetical trading does not involve financial risk, and no hypothetical trading record can completely account for the impact of financial risk of actual trading. for example, the ability to withstand losses or to adhere to a particular trading program in spite of trading losses are material points which can also adversely affect actual trading results. There are numerous other factors related to the markets in general or to the implementation of any specific trading program which cannot be fully accounted forin the preparation of hypothetical performance results and all which can adversely affect trading results.

Live Trades Disclosure:
This presentation is for educational purposes only and the opinions expressed are those of the presenter only. All trades presented should be considered hypothetical and should not be expected to be replicated in a live trading account.